Trial intelligence / Profile preview

Magnesium Balance in Citrate-based CVVH

NCT02194569Completed

Sponsor
Ziekenhuis Oost-Limburg
Start
Jul 2014
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of trisodium citrate in acute kidney injury (AKI) (2 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Magnesium balance of CVVH treatment at 24 hours. Started Jul 2014; status: completed.

02

Drugs

trisodium citrate
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT02194569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02194569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call